Search result for 'injectable'

CPP Investments to inject Rs 7,000 Cr in CtrlS Datacenters

June 18, 2026 16:39

CPP Investments commits Rs 7,000 crore to CtrlS Datacenters for India expansion. Funds will develop hyperscale data centers & AI infrastructure to meet surging demand.

Anupam Rasayan to Acquire Stake in Bliss GVS Pharma

May 24, 2026 14:21

Anupam Rasayan to acquire up to 43% stake in Bliss GVS Pharma for Rs 1,369 cr. Open offer for additional 26%.

Jubilant Pharmova Q4 Profit Declines 21%

May 22, 2026 15:59

Jubilant Pharmova Ltd reports 21% decline in Q4 net profit to Rs 119.3 cr. Revenue up, but profit impacted by exceptional items.

RBI Injects Liquidity via VRR Auction

May 22, 2026 14:54

RBI injects Rs 81,590 crore liquidity into banking system via 3-day VRR auction. Surplus liquidity drops, call money rates rise.

RBI USD/INR Swap Auction: Injecting Liquidity

May 20, 2026 18:26

RBI announces a USD 5 billion USD/INR swap auction on May 26 to inject long-term liquidity into the banking system. Details inside.

Glenmark Launches Generic Vancomycin in US

May 18, 2026 10:18

Glenmark Pharma launches generic vancomycin hydrochloride injection in the US. Bioequivalent to Fresenius Kabi. Strengthens injectable portfolio.

Dr Reddy''s Launches Semaglutide Injection in Canada

May 16, 2026 11:42

Dr Reddy''s launches generic Semaglutide injection in Canada for type 2 diabetes. First G7 country to authorize. Affordable GLP-1 therapies.

Eli Lilly Launches Alzheimer's Drug in India

May 13, 2026 15:06

Eli Lilly introduces Lormalzi in India, a new Alzheimer's therapy targeting amyloid plaques. Priced at Rs 91,688 per month.

Venus Remedies Antibiotic Approved in Argentina

May 7, 2026 12:00

Venus Remedies secures marketing approval in Argentina for Ceftriaxone, an antibiotic to treat bacterial infections. Expands Latin America presence.

Zydus Biologics USFDA Inspection: 7 Observations

May 6, 2026 13:10

USFDA concludes inspection at Zydus Biologics'' Ahmedabad injectable plant with 7 observations. No data integrity issues noted.

Emcure Pharma Q4 Net Profit Up 24% to Rs 243.74 Cr

May 5, 2026 15:23

Emcure Pharmaceuticals reports a 24% rise in Q4 net profit to Rs 243.74 crore, driven by strong international business growth.

Dr. Reddy''s Semaglutide Injection Approved in Canada

April 29, 2026 10:14

Dr. Reddy''s gets Health Canada approval for generic semaglutide injection for type-2 diabetes. First generic approval in Canada.

Alembic Pharma Gets USFDA Nod for Methotrexate Injection

April 16, 2026 12:36

Alembic Pharmaceuticals receives USFDA approval for generic Methotrexate injection, used to treat cancers and arthritis. Read more here.

Everstone Invests $270M in Apothecon Group

April 14, 2026 18:24

Everstone Capital invests USD 270 million in Apothecon Group, a Gujarat-based pharmaceuticals company, to expand its reach and R&D.

Sai Parenteral's Stock Lists at Premium

April 2, 2026 11:00

Sai Parenteral's stock debuts with a premium. IPO details, market performance, and company expansion plans. Learn more.

RBI Injects Liquidity via Variable Rate Repo

March 30, 2026 17:30

RBI injects Rs 84,582 crore into the banking system through variable rate repo (VRR) auctions to manage transient liquidity.

Sai Parenteral IPO Subscribed on Closing Day

March 27, 2026 19:03

Sai Parenteral''s IPO fully subscribed on the closing day, driven by institutional investors. IPO details and usage of proceeds.

Sai Parenteral IPO Subscribed 41% on Day 2

March 25, 2026 18:35

Sai Parenteral''s IPO saw 41% subscription on day 2. IPO details, subscription status, and company expansion plans inside.

Sai Parenteral IPO Subscribed 4% on Day 1

March 24, 2026 18:24

Sai Parenteral''s IPO received 4% subscription on day 1. IPO includes fresh issue & offer-for-sale. Proceeds to support expansion.

Sai Parenteral's IPO: Rs 122 Cr from Anchors

March 23, 2026 22:14

Sai Parenteral's raises over Rs 122 crore from anchor investors ahead of its IPO. IPO opens March 24, price band Rs 372-392.

RBI Injects Liquidity via VRR Auction

March 23, 2026 13:36

RBI infuses Rs 79,256 cr into banking system via overnight variable rate repo auction. Liquidity estimated in deficit of Rs 65,395.64 cr.

Generic Semaglutide Launched in India Post Patent Expiry

March 21, 2026 16:23

Torrent, Alkem, and USV launch generic Semaglutide brands in India after patent expiry. Affordable diabetes & weight loss treatment.

Generic Semaglutide Launched in India

March 21, 2026 10:51

Sun Pharma, Dr Reddy's, Glenmark launch generic semaglutide injection in India for diabetes and weight management. Affordable options now available.

RBI Injects Liquidity via VRR Auction

March 20, 2026 16:38

RBI injects Rs 25,101 crore into banking system via 3-day VRR auction. Liquidity lower than notified amount. Uneven distribution suggested.

Zydus, Torrent to Co-market Semaglutide Injection

March 18, 2026 16:56

Zydus Lifesciences and Torrent Pharma partner to co-market Semaglutide Injection for diabetes and weight management in India.

Sai Parenteral IPO: Price Band Rs 372-392

March 17, 2026 18:51

Sai Parenteral's Ltd files RHP for IPO, price band fixed at Rs 372-392 per share. IPO comprises fresh issue & offer-for-sale.

RBI Injects Liquidity via Repo Auction

March 17, 2026 16:47

RBI injects Rs 48,014 crore into the banking system through a 7-day variable rate repo auction to manage liquidity. Details inside.

RBI Injects Liquidity via OMO Purchase of G-Sec

March 13, 2026 16:25

RBI injects Rs 50,000 cr liquidity into banking system via OMO purchase of G-Sec. Surplus liquidity estimated at Rs 2.49 lakh crore.

RBI OMO: Rs 50,000 Crore Injection on March 13

March 11, 2026 19:21

RBI to inject Rs 50,000 crore into banking system via OMO purchase of government securities on March 13. Details on G-Sec and liquidity.

RBI Injects Liquidity via OMO Purchases

March 9, 2026 16:25

RBI injects Rs 50,000 crore liquidity into banking system via OMO purchases of government securities. Surplus liquidity at Rs 2.41 lakh crore.

Glenmark Launches Generic Sodium Phosphates Injection in US

February 27, 2026 15:48

Glenmark Pharmaceuticals to launch generic sodium phosphates injection in the US market in April 2026. Equivalent to Hosira Inc''s drug.

Piramal Pharma Q3 Loss: Rs 136 Cr, Inventory Impact

January 29, 2026 12:19

Piramal Pharma reports Rs 136 cr net loss in Q3 due to inventory destocking & slower order inflows. Sees recovery signs & invests in expansion.

RBI Injects Rs 2 Lakh Cr Liquidity into System

January 23, 2026 20:49

RBI announces liquidity injection measures of over Rs 2 lakh crore through VRR, USD/INR swap, and open market operations.

Lupin Inks Deal for Injectable Semaglutide

January 21, 2026 11:48

Lupin partners with Galenicum for injectable Semaglutide, a diabetes and weight management drug, across 23 countries.

Lupin Inks Semaglutide Deal with Galenicum

January 21, 2026 10:59

Lupin partners with Galenicum for injectable Semaglutide, a diabetes and weight management drug, across 23 countries.

Intas & IntegriMedical: Needle-Free IVF Injections

December 29, 2025 15:37

Intas partners with IntegriMedical for needle-free injection system in IVF & gynecology. Aims to improve patient experience and reduce anxiety.

Cipla Launches Inhalable Insulin for Diabetes

December 22, 2025 18:14

Cipla launches Afrezza, an orally inhaled insulin powder for diabetes patients in India. A needle-free alternative to injections.

Symbiotec Pharmalab IPO: Rs 2,180 Cr Raise

December 19, 2025 19:46

Symbiotec Pharmalab files for Rs 2,180 cr IPO. Includes fresh issue & OFS by promoters & investors. Details on stake sale & fund use.

Lupin Gets USFDA VAI Classification for Nagpur Plant

December 17, 2025 16:21

Lupin receives VAI classification from USFDA for its Nagpur injectable facility. Inspection report satisfactory. Shares up on BSE.

Ozempic for Type 2 Diabetes Launched in India

December 12, 2025 14:49

Novo Nordisk launches Ozempic in India for type 2 diabetes treatment. Weekly injection available at Rs 2,200. Weight management benefits.

RBI Injects Liquidity via OMO Purchase

December 11, 2025 22:24

RBI injects Rs 50,000 crore liquidity through Open Market Operation (OMO) purchases of government securities. Details inside.

Cipla Launches Obesity & Diabetes Drug Yurpeak

December 10, 2025 18:28

Cipla launches Yurpeak (tirzepatide), a weekly injectable for obesity and type-2 diabetes in India. Distribution rights from Eli Lilly.

Delius Pharma to Import Ceftriaxone API from China

December 10, 2025 16:55

Delius Pharma gets CDSCO approval to import Ceftriaxone Sodium API from China. Enhances supply, ensures quality, reduces dependency.

RBI USD/INR Swap Auction: Injecting Liquidity

December 8, 2025 19:29

RBI to conduct USD/INR buy-sell swap auction of USD 5 billion on Dec 16 to inject liquidity. OMO purchase auctions also planned.

Zydus Jarod Plant Gets USFDA VAI Classification

December 4, 2025 15:51

Zydus Lifesciences receives VAI classification from USFDA for its Jarod injectable manufacturing plant after inspection. Details inside.

Zydus & RK Pharma Ink Licensing Deal

November 26, 2025 14:11

Zydus Lifesciences partners with RK Pharma for oncology supportive care product in the US. Aims for 2026 filing.

Aurobindo Pharma: China Plant Loss, Break-Even Hope

November 23, 2025 11:18

Aurobindo Pharma facing losses at China plant, expects break-even by Q4 FY26. Growth driven by Pen-G, biosimilars, and injectables.

Glenmark Q2 Profit Surges 72% on AbbVie Deal

November 14, 2025 20:59

Glenmark Pharmaceuticals reports a 72% jump in Q2 net profit to Rs 610.43 cr, driven by the AbbVie ISB 2001 licensing deal.

Zydus Gets USFDA Nod for Leuprolide Acetate Injection

November 14, 2025 14:29

Zydus Lifesciences receives USFDA approval for generic Leuprolide Acetate injection, used in advanced prostatic cancer treatment.

Lupin Launches Generic Risperidone in US

November 14, 2025 13:42

Lupin launches generic Risperidone injection in the US with 180-day exclusivity for schizophrenia treatment. FDA approved.

Venus Remedies: Drugs Approved in Vietnam

November 9, 2025 12:22

Venus Remedies secures marketing authorisations for Methotrexate, Cefuroxime, Irinotecan in Vietnam. Expands export footprint in South Asia.

Gland Pharma Q2 PAT Up 12% to Rs 184 Cr

November 3, 2025 18:55

Gland Pharma reports Q2 PAT of Rs 184 cr, a 12% YoY increase, driven by Cenexi. Revenue rises to Rs 1,487 cr. USA up 10%, Europe 16%.

Jubilant Pharmova Profit Rises 17% in Q2

October 31, 2025 19:37

Jubilant Pharmova reports 17% rise in net profit to Rs 119.9 crore in Jul-Sep quarter. Revenue growth driven by CDMO sterile injectable business.

Glenmark Launches Ropivacaine Injection in US

October 23, 2025 13:34

Glenmark Pharma to launch generic Ropivacaine Hydrochloride injection for local anesthesia in the US. Distribution starts November 2025.

Jubilant Pharmova to Invest $300M in US

October 10, 2025 10:30

Jubilant Pharmova arm to invest USD 300 million in US by FY28 to double sterile injectable capacity. Expansion driven by demand.

Lupin: Long-Acting Injectable Platform Partnerships

October 9, 2025 15:46

Lupin seeks strategic partnerships for its long-acting injectable platform, PrecisionSphere, after USFDA approval. Extends product lifecycles.

Lupin Launches Generic Diabetes Drug in US

October 3, 2025 19:35

Lupin launches Liraglutide Injection, a generic diabetes medication, in the US market. Aims to improve glycemic control.

Aurobindo Pharma Receives USFDA Form 483

September 5, 2025 20:13

USFDA issues Form 483 with 8 observations to Aurobindo Pharma's Telangana unit. Company to respond within stipulated timelines.

Lupin Gets USFDA Nod for Risperidone Injection

September 3, 2025 15:00

Lupin receives USFDA approval for generic risperidone extended-release injectable suspension. Treatment for schizophrenia and bipolar disorder.

Caplin Point Gets USFDA Nod for Milrinone Injection

September 3, 2025 14:23

Caplin Point arm, Caplin Steriles, receives USFDA approval for generic milrinone lactate in 5% dextrose injection. Indicated for heart failure.

Glenmark Launches Fungal Infection Injection in US

August 19, 2025 13:08

Glenmark Pharmaceuticals USA to launch Micafungin injection for fungal infections in the US market in September 2025.

Glenmark Pharma Q1 PAT Down on US Litigation

August 14, 2025 19:37

Glenmark Pharmaceuticals Q1 FY26 PAT drops 86% to Rs 46.97 cr due to US litigation settlement. Revenue up marginally. Read details.

India's Fuel Exports Exempt from US Tariffs

August 1, 2025 16:39

India's petroleum exports to the US escape Trump's new tariffs, but the impact of potential penalties for Russia energy ties remains unclear.

Lupin Gets USFDA Nod for Generic Diabetes Drugs

July 24, 2025 13:47

Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments. Estimated annual sales of approved drugs total $582 million.

Biocon Launches Autoimmune Disease Drug in Australia

July 23, 2025 12:01

Biocon Biologics launches Nepexto, a biosimilar for autoimmune diseases like rheumatoid arthritis, in Australia. The drug will be distributed by Generic Health.

Aurobindo to Produce Long-Acting HIV Drug

July 15, 2025 12:04

Aurobindo Pharma will manufacture & supply long-acting injectable HIV treatment cabotegravir across 133 countries, including low & middle-income markets.

Panacea Biotec, Apotex Settle Dispute

July 9, 2025 18:51

Panacea Biotec and Apotex settle arbitration dispute over collaboration agreement breach. Panacea Biotec to receive USD 2 million.

Alembic gets USFDA nod for Doxorubicin Injection

June 30, 2025 12:15

Alembic Pharmaceuticals receives USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injection used to treat various cancers, including ovarian cancer, AIDS-related Kaposi's sarcoma,...

Novo Nordisk Launches Wegovy in India

June 24, 2025 13:26

Novo Nordisk launches Wegovy, its anti-obesity drug, in India. Targeting a large obese population, Wegovy aims to improve weight management and reduce cardiovascular risks. Available across India.

USFDA Closes Zydus Lifesciences Inspection with 2 Observations

June 18, 2025 19:10

USFDA completed a follow-up inspection of Zydus Lifesciences' oncology injectable unit in Ahmedabad, issuing two observations. No data integrity issues were found.

TPG Acquires 35% Stake in SCHOTT Poonawalla

May 6, 2025 16:48

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is expected to close in the first half of 2025.

AIFs Inject Rs 74K Cr in Indian Real Estate by Dec 2024: Anarock

April 21, 2025 13:35

Alternate Investment Funds (AIFs) have invested Rs 74,000 crore in Indian real estate till December 2024, the highest among all sectors, according to Anarock. Learn more about AIFs and their impact...

FPIs Inject Rs 8,500 cr in Indian Equities, Turning Net Buyers

April 20, 2025 11:29

Foreign Portfolio Investors (FPIs) infused Rs 8,500 crore in Indian equities last week, driven by renewed investor confidence and a resilient domestic economy. This marks a shift in sentiment after...

Cipla Gets USFDA Approval for Generic Cancer Drug

April 11, 2025 11:31

Cipla receives USFDA approval for its generic cancer treatment drug, paclitaxel protein-bound particles, a therapeutic equivalent to Bristol Myers Squibb's Abraxane. The drug is expected to launch...

OneSource Gets Brazil Approval for Flagship Facility

April 10, 2025 12:46

OneSource Specialty Pharma's Unit 2 in Bengaluru receives GMP certification from ANVISA, enabling the company to supply pharmaceutical products, including GLP-1s, to the Brazilian market.

Lupin Acquires UK-Based Renascience for £12.3 Million

April 2, 2025 19:37

Lupin, an Indian drug firm, has acquired UK-based Renascience Pharma for £12.3 million. The acquisition enhances Lupin's branded medicine portfolio and expands its reach in the UK market.

RBI Injects Liquidity with USD 10 Billion Forex Swap

March 24, 2025 20:52

The Reserve Bank of India conducted a US dollar-rupee swap worth USD 10 billion to inject long-term liquidity into the system, with the auction receiving strong demand.

SpiceJet Founder Injects Rs 294 Crore, Shareholding Rises

March 17, 2025 11:00

SpiceJet founder Ajay Singh will infuse Rs 294 crore into the airline through a promoter group entity, increasing promoter group's shareholding to over 33%.

RBI Forex Swap: USD 10 Billion Injection on March 24

March 10, 2025 20:18

Reserve Bank of India (RBI) to conduct a USD 10 billion forex swap on March 24 to inject liquidity into the banking system. The swap is a 36-month buy/sell transaction.

RBI Injects Rs 1.9 Lakh Crore Liquidity: OMO & USD/INR Swaps

March 5, 2025 20:22

Reserve Bank of India announces Rs 1.9 lakh crore liquidity infusion through open market operations (OMO) and USD/INR swaps to ease financial conditions.

RBI Injects Rs 1.9 Lakh Crore Liquidity: OMO, USD/INR Swaps

March 5, 2025 19:48

Reserve Bank of India announces Rs 1.9 lakh crore liquidity injection through open market operations (OMO) and USD/INR swaps to boost banking system liquidity.

Glenmark Launches Acetylcysteine Injection in US

March 3, 2025 09:54

Glenmark Pharmaceuticals has acquired generic Acetylcysteine injection for acetaminophen overdose treatment and launched it in the US market.

RBI Injects Liquidity via $10 Billion Forex Swap

February 28, 2025 15:59

The Reserve Bank of India conducted a USD 10 billion forex swap to inject long-term liquidity into the system, with the auction being oversubscribed. The move comes amid rupee weakness and global...

Glenmark Launches Generic Epinephrine Injection in US

February 27, 2025 10:13

Glenmark Pharmaceuticals launches generic Epinephrine injection in the US, eligible for 180 days of CGT exclusivity. The injection treats hypotension and allergic reactions.

RBI Injects Liquidity with USD 10 Billion Forex Swap

February 21, 2025 20:48

The Reserve Bank of India will conduct a USD 10 billion forex swap auction to inject long-term liquidity into the banking system. This move aims to address durable liquidity needs.

Glenmark Pharma Q3 Profit Rises to Rs 348 cr

February 14, 2025 20:12

Glenmark Pharmaceuticals reported a consolidated profit after tax of Rs 348 crore in Q3 FY25, driven by strong regional performance. The company also announced a USFDA inspection at its Indore...

Aurobindo Pharma Q3 Profit Dips 10% to Rs 846 cr

February 6, 2025 21:58

Aurobindo Pharma's net profit fell 10% to Rs 846 crore in Q3 FY25, while revenue rose to Rs 7,979 crore. The company attributes this to volume growth and new launches.

RBI to Inject Liquidity: USD/INR Swap Auction of $5 Billion

January 28, 2025 21:03

The Reserve Bank of India (RBI) will conduct a USD/INR buy-sell swap auction of USD 5 billion on January 31 to inject liquidity into the banking system. This is part of the RBI's Rs 1.5 lakh crore...

RBI Injects Liquidity: Rs 60,000 Crore Bond Purchase

January 27, 2025 18:15

The Reserve Bank of India (RBI) announced measures to inject liquidity into the banking system, including a Rs 60,000 crore government securities purchase and a USD/INR swap auction.

Venus Remedies Renews EU GMP Certification for Antibiotics & Oncology

January 21, 2025 14:51

Venus Remedies secures renewed EU GMP certification for its manufacturing facility, enabling expansion in European and global markets for antibiotics and oncology treatments.

Akums Group Inks €200 Million Deal for European Market

December 26, 2024 16:28

Akums Group has signed a €200 million agreement with a global pharma firm for manufacturing and supplying formulations in the European market. The deal will see Akums Group produce oral liquid...

Pricol Acquires Sundaram Auto Components' Injection Moulding Biz - Rs 215 Crore Deal

December 2, 2024 17:51

Pricol to acquire Sundaram Auto Components' injection moulding business for Rs 215 crore, boosting its topline by Rs 730 crore. The acquisition is a debt-free all-cash deal and subject to adjustments.

Pharma Companies Invest in Telangana Pharma City

November 22, 2024 22:08

Six pharma companies, including Dr Reddy's Laboratories, Aurobindo Pharma, and Hetero Labs, have signed MoUs with the Telangana government to invest over Rs 5,260 crore in Pharma City, creating...

Deutsche Bank Injects Rs 5,113 Cr into India Operations

November 6, 2024 11:08

Deutsche Bank has infused Rs 5,113 crore into its India operations, the largest capital allocation in recent years, to expand across business lines.

Govt Injects Rs 1,650 cr in RINL to Keep it Afloat

November 3, 2024 11:38

The Indian government has infused Rs 1,650 crore in RINL, a struggling state-owned steel company, to keep it operational. The move comes as the government explores privatization options for the...

Piramal Pharma to Invest USD 85 mn in Capex This Fiscal

October 27, 2024 11:23

Piramal Pharma, aiming for USD 2 billion revenue by FY30, will invest USD 85 million in capex this fiscal for capacity expansion, maintenance, and de-bottlenecking of CDMO sites.

Wockhardt Seeks Approval for Diabetes Drug Aspart Injection

October 16, 2024 11:38

Wockhardt has filed for marketing approval of its fast-acting insulin analog, Aspart injection, with the DCGI in India. This move aims to address the growing diabetes epidemic and provide patients...

Strides Pharma CDMO Arm Raises Rs 801 Cr in Pre-Listing Round

October 16, 2024 10:46

Strides Pharma Science's CDMO arm, OneSource Specialty Pharma, secures Rs 801 crore in pre-listing funding from investors, aiming to accelerate growth and expand operations.

Amneal Pharmaceuticals to Invest $200 Million in India for 2 New Plants

October 8, 2024 18:19

Amneal Pharmaceuticals will invest up to $200 million in India over the next four to five years to build two new manufacturing facilities in Ahmedabad. The facilities will focus on peptide...

Alma Lasers Sees Huge Growth Potential in India's Unique Market

September 30, 2024 20:23

Alma Lasers, a global leader in energy-based medical and aesthetic solutions, sees huge growth potential in India's unique market. The company plans to expand its product portfolio in the country...

Aurobindo Acquires GLS Pharma for Rs 22.5 Crore

September 18, 2024 16:01

Aurobindo Pharma Ltd will acquire the remaining 49% stake in GLS Pharma Ltd for Rs 22.5 crore, making it a wholly-owned subsidiary. The deal is expected to be completed by December 31, 2024.

Strides Pharma Science Creates OneSource Specialty Pharma CDMO

September 11, 2024 18:21

Strides Pharma Science has received shareholder and creditor approval to establish OneSource, a specialty pharma CDMO, by integrating its Oral Technologies, Sterile Injectables, and biologics...

Aurobindo Pharma Gets First USFDA Approval for Generic Anaesthesia

September 11, 2024 17:58

Aurobindo Pharma's subsidiary, Eugia Steriles, has received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, a generic anaesthesia medication.

Eugia Steriles' Injectable Facility Gets FDA Approval

September 11, 2024 14:23

Eugia Steriles's new injectables facility in Andhra Pradesh has received its first product approval from the US FDA, marking a significant milestone for the company.

USFDA Issues Warning Letter to Zydus Lifesciences for Injectables Facility

August 30, 2024 15:27

Zydus Lifesciences receives a warning letter from the USFDA for its injectables manufacturing facility in Jarod, Gujarat, due to violations of manufacturing regulations. The letter does not mention...

Lupin Launches Generic Cancer Drug in US - Doxorubicin Hydrochloride Liposome Injection

August 29, 2024 16:11

Lupin has launched a generic version of Doxorubicin Hydrochloride Liposome Injection (Doxil) in the US market, treating ovarian cancer, AIDS-related Kaposi's Sarcoma, and multiple myeloma.

Akums Drugs Q1 Profit Jumps to Rs 60 Cr | Revenue Up - Business News

August 26, 2024 12:37

Akums Drugs and Pharmaceuticals reported a consolidated net profit of Rs 60 crore for Q1 FY24, a significant turnaround from last year's loss. Total income also rose to Rs 1,026 crore.

Telangana CM Partners with World Bank for State Development

August 7, 2024 22:07

Telangana CM Revanth Reddy meets World Bank President Ajay Banga to discuss partnerships on skills development, urban rejuvenation, healthcare, and more, aiming to improve the lives of over 4 crore...

Thermax Q1 Profit Surges 82% to Rs 109 Crore

August 1, 2024 16:55

Thermax reported a strong Q1 FY25, with net profit jumping 82% to Rs 109 crore driven by higher revenues. The company also saw a 13% increase in operating revenue and unveiled a new manufacturing...

Senores Pharma IPO: Rs 500 Cr Raise, US Expansion

July 29, 2024 13:33

Senores Pharmaceuticals files IPO papers with Sebi to raise Rs 500 crore, aiming to expand its US operations and set up a new manufacturing facility.

Jubilant Pharmova Q1 Profit Surges to Rs 481.8 Cr

July 19, 2024 16:46

Jubilant Pharmova's net profit jumped to Rs 481.8 crore in Q1 FY24, driven by gains from the sale of its investment in SOFIE Biosciences. Revenue also grew year-on-year.

USFDA Classifies Zydus Plant as 'Official Action Indicated'

July 18, 2024 18:44

USFDA has issued an 'Official Action Indicated' classification for Zydus Lifesciences's injectables plant in Gujarat, indicating potential regulatory action.

USFDA Classifies Zydus Lifesciences Jarod Unit 'OAI' - What It Means

July 18, 2024 17:55

USFDA classifies Zydus Lifesciences' Jarod injectables facility as 'Official Action Indicated' following inspection. Learn about the implications and what it means for the company.

Alembic Gets USFDA Nod for Generic Selexipag Injection

July 15, 2024 13:32

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Selexipag injection, a treatment for pulmonary arterial hypertension. The company may be eligible for 180 days of generic...

FPIs Inject Rs 7,900cr in Indian Equities in July - Times of India

July 7, 2024 11:03

Foreign investors poured over Rs 7,900 crore into Indian equities in the first week of July, taking total FPI investment to Rs 1.16 lakh crore in 2024. Find out what's driving this trend and what...

KKR Acquires Baby Memorial Hospital for Rs 2k cr

July 1, 2024 20:01

Global PE major KKR acquires a controlling stake in Kerala-based Baby Memorial Hospital for Rs 2,000 crore, aiming to expand its healthcare network in India.

Zydus to make Biotax 1g injection available with 10ml sterile water post Nepal regulator's objection

June 19, 2024 16:03

Zydus Life Sciences will now provide 10ml sterile water with its Biotax 1g injection in Nepal after the country's drug regulator objected to the earlier 5ml supply. The company clarified that the...

Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection

June 17, 2024 13:29

Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...

Hydrogen Injection in Steel: MECON Invites Bids

June 13, 2024 20:51

MECON invites bids for pilot projects on hydrogen injection in sponge iron plants and blast furnaces to promote decarbonization and sustainability in the steel industry.

Dr Reddy's Licenses Cyclophosphamide Injection for Cancer Treatment

June 12, 2024 17:59

Dr Reddy's Laboratories has signed a licensing agreement with Ingenus Pharmaceuticals to commercialize Cyclophosphamide injection for cancer treatment in the US.

Cipla Gets USFDA Nod for Generic Lanreotide Injection

May 22, 2024 12:13

Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.

SII Invests in Needle-Free Injection Tech

May 17, 2024 11:00

Serum Institute of India (SII) acquires 20% stake in IntegriMedical, a company developing a needle-free injection system. The technology aims to revolutionize vaccine administration, offering a...

Gland Pharma Gets USFDA Approval for Generic Edaravone Injection

May 7, 2024 12:56

Gland Pharma receives USFDA approval for its generic Edaravone injection, used to treat amyotrophic lateral sclerosis (ALS). The company expects to launch the product through its marketing partner...

KKR Acquires Healthium Medtech for Rs 7,000 Cr

May 6, 2024 20:33

KKR has acquired medical device firm Healthium Medtech from Apax Partners for up to Rs 7,000 crore. The deal marks KKR's latest investment in the healthcare sector in India and the Asia Pacific.

KKR Acquires Healthium Medtech from Apax Funds

May 6, 2024 19:40

KKR has acquired medical device firm Healthium Medtech from Apax Partners. The acquisition will be made by a special purpose vehicle owned by KKR-managed funds, which will acquire a controlling...

Caplin Point Labs Gets Colombia Regulatory Approval for Softgel Capsules

May 6, 2024 13:16

Caplin Point Labs receives regulatory approval from Colombia's INVIMA for its softgel capsules division in Puducherry, expanding its reach in Latin America.

Maiva Pharma Raises Rs 1,000 Cr from PE Funds

May 2, 2024 17:09

Maiva Pharma secures Rs 1,000 crore funding from Morgan Stanley Private Equity Asia and India Life Sciences Fund to expand its injectables manufacturing capabilities.

Sanofi Launches Diabetes Drug Soliqua in India

April 30, 2024 12:38

Sanofi India has launched its diabetes drug Soliqua, a combination of insulin glargine and lixisenatide, offering a once-daily injectable treatment option for adults with type 2 diabetes.

Zydus Lifesciences Gets USFDA Observations - PTI

April 24, 2024 12:16

Zydus Lifesciences receives 10 observations from the USFDA following an inspection of its injectable manufacturing facility in Gujarat. The company will work to address the observations.

Natco Pharma Faces US Lawsuit Over Diazepam Injection

April 18, 2024 10:55

Fresenius Kabi has filed a complaint against Natco Pharma in a US district court over the marketing of Diazepam injection prefilled syringes. Natco Pharma plans to defend the lawsuit.

Gland Pharma Gets USFDA Approval for Generic Breast Cancer Drug

April 8, 2024 16:47

Gland Pharma receives USFDA approval for Eribulin Mesylate Injection, a generic breast cancer drug, expected to be the first in the market. The company plans to launch the product soon.

Aurobindo Pharma Unit Gets USFDA Observations

April 5, 2024 18:26

Aurobindo Pharma's subsidiary, Eugia Steriles, received three observations from the USFDA after an inspection of their new injectable facility in Andhra Pradesh.

Sanofi's New Polio Vaccine Approved in India

April 5, 2024 14:57

Sanofi has received approval for its IMOVAX-Polio vaccine in India, replacing ShanIPV. The new vaccine has been used globally for over 40 years and ensures continued polio protection.

Lupin Launches Ganirelix Acetate Injection in US - Fertility Treatment

February 15, 2024 14:06

Lupin launches Ganirelix Acetate injection in the US, a generic for fertility treatments, approved by the USFDA. The injection inhibits premature LH surges during controlled ovarian hyperstimulation.

Glenmark Reports Q3 Loss: Lower Domestic Sales Impact

February 14, 2024 21:56

Glenmark Pharmaceuticals reported a net loss of Rs 351 crore in Q3 FY24, driven by lower domestic sales due to a change in distribution model. The company expects its US business to rebound in Q4.

Eris Lifesciences Acquires 51% Stake in Swiss Parenterals

February 13, 2024 17:48

Eris Lifesciences has acquired a 51% stake in Swiss Parenterals, a leading sterile injectable manufacturer, for Rs 637.5 crore. The acquisition strengthens Eris's India footprint and complements...

Thermax Acquires TSA Process Equipments: Water Solutions Expansion

February 6, 2024 19:44

Thermax Ltd acquires 100% stake in TSA Process Equipments, expanding its water division's capabilities to provide end-to-end solutions for purified water.

Zydus Launches Oral Prostate Cancer Drug - Rexigo

January 30, 2024 15:53

Zydus Lifesciences introduces Rexigo, an oral medication for prostate cancer, offering a more affordable and convenient treatment option compared to injectable therapies.

Glenmark Launches Biosimilar Antidiabetic Drug in India

January 3, 2024 10:51

Glenmark Pharmaceuticals launches Lirafit, a biosimilar antidiabetic drug, in India at a lower cost than Liraglutide, providing effective treatment for type 2 diabetes mellitus.

Aurobindo Pharma Gets USFDA Approval for Generic Antifungal Injection

December 27, 2023 15:11

Aurobindo Pharma has received USFDA approval to manufacture and market generic Posaconazole injection, used to prevent serious fungal infections. The injection will be launched in December 2023.

Zydus Lifesciences & Daewoong Partner on Generic Lupron Depot

December 11, 2023 11:18

Zydus Lifesciences and Daewoong Pharmaceutical are collaborating to develop and commercialize a generic version of Leuprolide Acetate for depot suspension in the US market.

Zydus Lifesciences Gets USFDA Approval for Generic Methylene Blue Injection

December 6, 2023 16:56

Zydus Lifesciences has received USFDA approval to market a generic version of ProvayBlue injection, a treatment for acquired methemoglobinemia. The company's vial presentation offers a...

Company Name
Price
Volume

Meesho
170.55 (+ 3.77)
24846181

Vodafone-Idea
15.02 (+ 0.67)
23546904

YES-Bank
25.49 (+ 1.51)
17457404

IFCI
82.34 ( -8.58)
15648708

Enbee-Trade-and-Fin
0.33 ( 0.00)
15219819

MORE NEWS

Maharashtra MANTRA Centre: Patent Filing & IP Support

GeM & CSC-SPV Expand Govt Procurement; Amazon Prime Day Sale

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2026	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Advertise with us